Multiple pathways lead to NK cell activation and anti-cancer cytotoxicity, including cytokine stimulation, NKG2D activation, and stimulation by other cells types,25,37 all of which were activated by QBKPN administration. This evidence concerns the gene KLRK1 and cancer.